Original Article
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 28, 2012; 18(36): 5042-5050
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5042
Tumor necrosis factor alpha increases intestinal permeability in mice with fulminant hepatic failure
Guo-Zhen Li, Zhao-Han Wang, Wei Cui, Jin-Long Fu, Yu-Rong Wang, Pei Liu
Guo-Zhen Li, Zhao-Han Wang, Wei Cui, Jin-Long Fu, Yu-Rong Wang, Pei Liu, Department of Infectious Diseases, the First Affiliated Hospital, China Medical University, Shenyang 110001, Liaoning Province, China
Author contributions: Li GZ and Wang ZH contributed equally to this work; Liu P designed research; Li GZ, Wang ZH and Cui W did the experiment; Fu JL analyzed dates; Wang ZH and Wang YR wrote the paper.
Supported by National Ministry of Health of China, No. 97100252
Correspondence to: Dr. Pei Liu, Department of Infectious Diseases, the First Affiliated Hospital, China Medical University, No. 155 Nanjing Street, Shenyang 110001, Liaoning Province, China. syliupei2003@yahoo.com.cn
Telephone: +86-24-83283091 Fax: +86-24-83282805
Received: March 14, 2012
Revised: May 29, 2012
Accepted: June 8, 2012
Published online: September 28, 2012
Abstract

AIM: To determine the effect of tumor necrosis factor alpha (TNF-α) on intestinal permeability (IP) in mice with fulminant hepatic failure (FHF), and the expression of tight junction proteins.

METHODS: We selected D-lactate as an index of IP, induced FHF using D-galactosamine/lipopolysaccharide and D-galactosamine/TNF-α, assessed the results using an enzymatic-spectrophotometric method, transmission electron microscopy, immunohistochemistry, Western blotting and real-time quantitative polymerase chain reaction. The effect of the administration of anti-TNF-α immunoglobulin G (IgG) antibody, before the administration of D-galactosamine/lipopolysaccharide, on TNF-α was also assessed.

RESULTS: IP was significantly increased in the mouse model of FHF 6 h after injection (13.57 ± 1.70 mg/L, 13.02 ± 1.97 mg/L vs 3.76 ± 0.67 mg/L, P = 0.001). Electron microscopic analysis revealed tight junction (TJ) disruptions, epithelial cell swelling, and atrophy of intestinal villi. Expression of occludin and claudin-1 mRNA was significantly decreased in both FHF models (occludin: 0.57 ± 0.159 fold vs baseline, P = 0.000; claudin-1: 0.3067 ± 0.1291 fold vs baseline, P = 0.003), as were the distribution density of proteins in the intestinal mucosa and the levels of occludin and claudin-1 protein (occludin: 0.61 ± 0.0473 fold vs baseline, P = 0.000; claudin-1: 0.6633 ± 0.0328 fold vs baseline, P = 0.000). Prophylactic treatment with anti-TNF-α IgG antibody prevented changes in IP (4.50 ± 0.97 mg/L vs 3.76 ± 0.67 mg/L, P = 0.791), intestinal tissue ultrastructure, and the mRNA levels of occludin and claudin-1 expression (occludin: 0.8865 ± 0.0274 fold vs baseline, P = 0.505; claudin-1: 0.85 ± 0.1437 fold vs baseline, P = 0.1), and in the protein levels (occludin: 0.9467 ± 0.0285 fold vs baseline, P > 0.05; claudin-1: 0.9533 ± 0.0186 fold vs baseline, P = 0.148).

CONCLUSION: Increased in IP stemmed from the downregulation of the TJ proteins occludin and claudin-1, and destruction of the TJ in the colon, which were induced by TNF-α in FHF mice.

Keywords: Tumor necrosis factor alpha, Fulminant hepatic failure, Intestinal permeability, Occludin, Claudin-1